Clinical trials have compared nebivolol at target dosages of 5 and 10 mg once daily with placebo and, in small trials, with carvedilol in the treatment of adults with chronic heart failure.

[62] After a 4-week placebo run-in period, patients were randomized to receive either placebo, nebivolol 1, 5 or 10 mg once daily, or HCTZ 12.5 or 25 mg once daily, or one of six possible ...

Discover all the brand names or Trade names of generic drug called Nebivolol. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...